pentoxifylline has been researched along with Hyperglycemia in 6 studies
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD), which includes simple steatosis, steatohepatitis, fibrosis, and cirrhosis, is characterised by abnormal fat accumulation in the liver in the absence of excessive alcohol intake." | 5.43 | Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation. ( Chang, ML; Chao, J; Cheng, HY; Liao, JW; Pao, LH; Peng, WH; Ye, JH, 2016) |
| "Nonalcoholic fatty liver disease (NAFLD), which includes simple steatosis, steatohepatitis, fibrosis, and cirrhosis, is characterised by abnormal fat accumulation in the liver in the absence of excessive alcohol intake." | 1.43 | Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation. ( Chang, ML; Chao, J; Cheng, HY; Liao, JW; Pao, LH; Peng, WH; Ye, JH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehanna, OM | 1 |
| El Askary, A | 1 |
| Al-Shehri, S | 1 |
| El-Esawy, B | 1 |
| Kashani-Amin, E | 1 |
| Yaghmaei, P | 1 |
| Larijani, B | 1 |
| Ebrahim-Habibi, A | 1 |
| Zhiliuk, VI | 1 |
| Mamchur, VI | 1 |
| Pavlov, SV | 1 |
| Ye, JH | 1 |
| Chao, J | 1 |
| Chang, ML | 1 |
| Peng, WH | 1 |
| Cheng, HY | 1 |
| Liao, JW | 1 |
| Pao, LH | 1 |
| Bolick, DT | 1 |
| Hatley, ME | 1 |
| Srinivasan, S | 1 |
| Hedrick, CC | 1 |
| Nadler, JL | 1 |
| Costelli, P | 1 |
| Almendro, V | 1 |
| Figueras, MT | 1 |
| Reffo, P | 1 |
| Penna, F | 1 |
| Aragno, M | 1 |
| Mastrocola, R | 1 |
| Boccuzzi, G | 1 |
| Busquets, S | 1 |
| Bonelli, G | 1 |
| Lopez Soriano, FJ | 1 |
| Argilés, JM | 1 |
| Baccino, FM | 1 |
6 other studies available for pentoxifylline and Hyperglycemia
| Article | Year |
|---|---|
Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hyperglycemia; Hypog | 2018 |
Xanthine derivatives as activators of alpha-amylase: hypothesis on a link with the hyperglycemia induced by caffeine.
Topics: Animals; Blood Glucose; Caffeine; Enzyme Activation; Enzyme Inhibitors; Hyperglycemia; Pancreas; Pan | 2013 |
[Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia].
Topics: Alloxan; Amnesia; Animals; Avoidance Learning; Cerebral Cortex; Cognition; Cytidine Diphosphate Chol | 2015 |
Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Dyslipidemias; Fa | 2016 |
Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Connective Tissue Growth F | 2003 |
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy.
Topics: Animals; Blotting, Western; Cachexia; Calcineurin; Carcinoma, Hepatocellular; DNA; DNA Primers; Elec | 2007 |